| |
 |
|
|
|
|
|
Poster: 2
Visits: 180
Title: Leap-012: A Randomized, Double-Blind, Phase 3 Study Of Pembrolizumab Plus Lenvatinib In Combination With Transarterial Chemoembolization (Tace) In Patients With Intermediate-Stage Hepatocellular Carcinoma (Hcc) Not Amenable To Curative Treatment
Authors: Richard Finn , R.S. FINN, S. OGASAWARA, J.M. LLOVET, A.B. EL-KHOUEIRY, A. VOGEL, D.C. MADOFF, Z. REN, K. MODY, J.J. LI, A.B. SIEGEL, L. DUBROVSKY, M. KUDO
Centre:
|
|
You must be registered to reply or comment.
|
|
LEAP-012: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF PEMBROLIZUMAB PLUS LENVATINIB IN COMBINATION WITH TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA (HCC) NOT AMENABLE TO CURATIVE TREATMENT
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre:
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 3
Visits: 186
Title: Ramucirumab For Patients With Advanced Hepatocellular Carcinoma And Elevated Alpha Fetoprotein Following A Non-Sorafenib Based Systemic Therapy: Interim Results From An Expansion Cohort Of The Phase 3 Reach-2 Study
Authors: David Mcilwain ,
Centre:
|
|
|
|
